PET Imaging May Predict Early Immunotherapy Response – Cancer Network
|
PET Imaging May Predict Early Immunotherapy Response
Cancer Network Researchers provided a preclinical proof of concept for the use of granzyme B, a downstream effector of tumoral cytotoxic T cells, as an early biomarker for tumors responding to immunotherapy with checkpoint inhibitors. “In our study, we found a marker … |
